C. difficile is a bacterium that causes diarrhea and sometimes can lead to serious intestinal conditions or complications.
Valneva’s unpartnered Clostridium difficile candidate – VLA84
- Valneva is developing VLA84, a vaccine candidate against Clostridium difficile, a leading cause of life threatening, healthcare associated infections worldwide.
- Valneva completed Phase 2 development of its prophylactic vaccine candidate against Clostridium difficile infection.
- VLA84 is currently Phase 3-ready and Valneva seeks to partner it.
Additional information about Clostridium difficile: